Risk factors and clinical significance of severe mycoplasma pneumoniae pneumonia
10.3760/cma.j.issn.1673-4408.2016.07.002
- VernacularTitle:重症肺炎支原体肺炎危险因素分析及临床意义
- Author:
Xiaoyuan JING
- Publication Type:Journal Article
- Keywords:
Severe mycoplasma pneumoniae pneumonia;
Risk factors;
Glucocorticoid
- From:
International Journal of Pediatrics
2016;43(7):519-522
- CountryChina
- Language:Chinese
-
Abstract:
Mycoplasma pneumoniae pneumonias are common in children.In recent years,the incidence of refractory mycoplasma pneumonia has been increasing,and some of the severe children have a poor response to macrolide antibiotics.However,the effect of glucoconicoid therapy may have unexpected results.The recognition of severe mycoplasma pneumonia risk factors may contribute to intervent with glucocorticoid early,reduce the occurrence of severe mycoplasma pneumonia,and improve the prognosis.Clinical studies have found that clinical manifestations,imaging findings,laboratory tests and other factors are related to the occurrence of severe mycoplasma pneumonia.In this paper,the risk factors that may be associated with accurrence of severe mycoplasma pneumonias are reviewed.